These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30394316)

  • 1. SREBP-2 aggravates breast cancer associated osteolysis by promoting osteoclastogenesis and breast cancer metastasis.
    Jie Z; Xie Z; Xu W; Zhao X; Jin G; Sun X; Huang B; Tang P; Wang G; Shen S; Qin A; Fan S
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):115-125. PubMed ID: 30394316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade.
    Zhang L; Yang Y; Liao Z; Liu Q; Lei X; Li M; Saijilafu ; Zhang Z; Hong D; Zhu M; Li B; Yang H; Chen J
    Theranostics; 2020; 10(15):6638-6660. PubMed ID: 32550895
    [No Abstract]   [Full Text] [Related]  

  • 3. Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway.
    Jiang W; Rixiati Y; Huang H; Shi Y; Huang C; Jiao B
    Cancer Med; 2020 Nov; 9(21):8173-8185. PubMed ID: 32976685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plumbagin inhibits osteoclastogenesis and reduces human breast cancer-induced osteolytic bone metastasis in mice through suppression of RANKL signaling.
    Sung B; Oyajobi B; Aggarwal BB
    Mol Cancer Ther; 2012 Feb; 11(2):350-9. PubMed ID: 22090419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-11 produced by breast cancer cells augments osteoclastogenesis by sustaining the pool of osteoclast progenitor cells.
    McCoy EM; Hong H; Pruitt HC; Feng X
    BMC Cancer; 2013 Jan; 13():16. PubMed ID: 23311882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
    Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
    Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis.
    Liang M; Ma Q; Ding N; Luo F; Bai Y; Kang F; Gong X; Dong R; Dai J; Dai Q; Dou C; Dong S
    Cell Death Dis; 2019 Apr; 10(5):353. PubMed ID: 31040267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis.
    Das S; Samant RS; Shevde LA
    J Biol Chem; 2011 Mar; 286(11):9612-22. PubMed ID: 21169638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geraniin suppresses RANKL-induced osteoclastogenesis in vitro and ameliorates wear particle-induced osteolysis in mouse model.
    Xiao F; Zhai Z; Jiang C; Liu X; Li H; Qu X; Ouyang Z; Fan Q; Tang T; Qin A; Gu D
    Exp Cell Res; 2015 Jan; 330(1):91-101. PubMed ID: 25016282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer metastasis to the bone: mechanisms of bone loss.
    Chen YC; Sosnoski DM; Mastro AM
    Breast Cancer Res; 2010; 12(6):215. PubMed ID: 21176175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stachydrine prevents LPS-induced bone loss by inhibiting osteoclastogenesis via NF-κB and Akt signalling.
    Meng J; Zhou C; Zhang W; Wang W; He B; Hu B; Jiang G; Wang Y; Hong J; Li S; He J; Yan S; Yan W
    J Cell Mol Med; 2019 Oct; 23(10):6730-6743. PubMed ID: 31328430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis.
    Marino S; Bishop RT; Logan JG; Mollat P; Idris AI
    Cancer Lett; 2017 Dec; 410():180-190. PubMed ID: 28965856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis.
    Li X; Liang Y; Lian C; Peng F; Xiao Y; He Y; Ma C; Wang Y; Zhang P; Deng Y; Su Y; Luo C; Kong X; Yang Q; Liu T; Hu G
    Theranostics; 2021; 11(20):9821-9832. PubMed ID: 34815788
    [No Abstract]   [Full Text] [Related]  

  • 14. Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways.
    Wu Z; Wu H; Li C; Fu F; Ding J; Shao S; Li K; Yu X; Su Y; Liang J; Lin X; Yuan G; Zhou J; Song F; Zhao J; Xu J; Liu Q; Xu F
    J Cell Physiol; 2019 Aug; 234(10):17812-17823. PubMed ID: 30815894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis.
    Ohshiba T; Miyaura C; Inada M; Ito A
    Br J Cancer; 2003 Apr; 88(8):1318-26. PubMed ID: 12698202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin inhibits breast cancer-induced osteolysis by inhibiting osteoclast formation and breast cancer cell proliferation.
    Li J; Feng W; Lu H; Wei Y; Ma S; Wei L; Liu Q; Zhao J; Wei Q; Yao J
    J Cell Physiol; 2019 Aug; 234(8):12663-12675. PubMed ID: 30536376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption.
    Wang L; Guo X; Zhou W; Ding Y; Shi J; Wu X; Liu Y; Xu Y; Yang H; Geng D
    Acta Biomater; 2018 Jun; 73():488-499. PubMed ID: 29656074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling.
    Wang J; Rouse C; Jasper JS; Pendergast AM
    Sci Signal; 2016 Feb; 9(413):ra12. PubMed ID: 26838548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in mice.
    Shao S; Fu F; Wang Z; Song F; Li C; Wu ZX; Ding J; Li K; Xiao Y; Su Y; Lin X; Yuan G; Zhao J; Liu Q; Xu J
    J Cell Physiol; 2019 Aug; 234(8):12701-12713. PubMed ID: 30515812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades.
    Song F; Wei C; Zhou L; Qin A; Yang M; Tickner J; Huang Y; Zhao J; Xu J
    J Cell Physiol; 2018 Feb; 233(2):1723-1735. PubMed ID: 28681916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.